Humanwell Healthcare Group Co Ltd operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Humanwell Healthcare Group Co Ltd with three other
companies in this sector in China:
Shenzhen Neptunus Bioengineer
sales of 11.12 billion Chinese Renmimbi [US$1.65 billion]
of which 85%
was Pharmaceutical Distribution),
Jiangsu Hengrui Medicine Co., Ltd.
(9.32 billion Chinese Renmimbi [US$1.38 billion]
of which 98%
was Medicinal Manufacturing), and
Beijing Tongrentang Co., Ltd.
(10.79 billion Chinese Renmimbi [US$1.60 billion]
of which 51%
Humanwell Healthcare Group Co Ltd reported sales of 10.05 billion Chinese Renmimbi (US$1.49 billion)
December of 2015.
increase of 42.5%
versus 2014, when the company's sales were 7.05 billion Chinese Renmimbi.
Sales at Humanwell Healthcare Group Co Ltd have increased during each of the previous five years
(and since 2010, sales have increased a total of 356%).
Sales of Medication and Health Products saw an increase
44.7% in 2015, from
6.87 billion Chinese Renmimbi to 9.94 billion Chinese Renmimbi.
Not all segments of Humanwell Healthcare Group Co Ltd experienced an increase in sales in 2015:
sales of Other Main Operations fell 38.7% to 112.33 million Chinese Renmimbi.
(However, this segment's sales were only a very small portion of the company's overall sales).